Variant report

Variant	nsv432985
Chromosome Location	chr6:167825871-167827808
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr6:167823826..167826272-chr6:167829672..167831832,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-TCP10-3	chr6:167825862-167825976	ucscGeneNc_uc003qvy_1
2	lnc-TCP10-3	chr6:167826637-167827774	ucscGeneNc_uc003qvy_1

Extended variants
information (count: 89 )
Associated
traits (count: 80 )

Variant overlapped rSNPs/rCNVs (count:89 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs4075645	chr6:167825871-167825872	Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
2	rs4077196	chr6:167825895-167825896	Weak transcription Bivalent Enhancer	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
3	rs530453792	chr6:167825943-167825944	Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
4	rs62428350	chr6:167825955-167825956	Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
5	rs4395701	chr6:167826000-167826001	Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs558805740	chr6:167826022-167826023	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs12210912	chr6:167826029-167826030	Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs66613411	chr6:167826032-167826033	Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs552712195	chr6:167826078-167826079	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs372582665	chr6:167826086-167826087	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs4708784	chr6:167826110-167826111	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs9347221	chr6:167826114-167826115	Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs12197382	chr6:167826180-167826181	Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
14	rs147670202	chr6:167826196-167826197	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs368406552	chr6:167826205-167826206	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs142318018	chr6:167826232-167826233	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs371504382	chr6:167826239-167826240	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs575425730	chr6:167826241-167826242	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs547327465	chr6:167826298-167826299	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs568636108	chr6:167826308-167826309	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs529539565	chr6:167826338-167826339	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs551038166	chr6:167826361-167826362	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs193127593	chr6:167826399-167826400	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs376756448	chr6:167826402-167826403	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs569291916	chr6:167826416-167826417	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs539817099	chr6:167826429-167826430	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs116407935	chr6:167826463-167826464	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs117345526	chr6:167826508-167826509	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs534567981	chr6:167826563-167826564	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs79951794	chr6:167826578-167826579	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs147022514	chr6:167826582-167826583	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs563115601	chr6:167826649-167826650	Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
33	rs185622956	chr6:167826657-167826658	Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
34	rs9346745	chr6:167826664-167826665	Weak transcription Bivalent Enhancer	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs575294134	chr6:167826672-167826673	Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
36	rs545887933	chr6:167826697-167826698	Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
37	rs13211981	chr6:167826752-167826753	Weak transcription Bivalent Enhancer	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs76999547	chr6:167826769-167826770	Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
39	rs540900290	chr6:167826808-167826809	Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
40	rs9347222	chr6:167826815-167826816	Weak transcription Bivalent Enhancer	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs115893036	chr6:167826836-167826837	Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
42	rs550938811	chr6:167826847-167826848	Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
43	rs563099739	chr6:167826848-167826849	Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
44	rs533226612	chr6:167826894-167826895	Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
45	rs9364941	chr6:167826896-167826897	Weak transcription Bivalent Enhancer	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs75767184	chr6:167826902-167826903	Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
47	rs533963572	chr6:167826947-167826948	Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
48	rs11758957	chr6:167826953-167826954	Weak transcription Bivalent Enhancer	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs138191135	chr6:167827016-167827017	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
50	rs116267270	chr6:167827056-167827057	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a

Variant related diseases (count:80)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Testicular germ cell tumor	18059402	CNVD
Chordoma	18071362	CNVD
Glioblastoma multiforme	19435819	CNVD
Developmental delay	21147756	CNVD
Ovarian cancer	21720365	CNVD
abnormal development	18461090	CNVD
Epilepsy	22083797	CNVD
Myelofibrosis	22110671	CNVD
chordoma	19801981	CNVD
Myxofibrosarcoma	16751306	CNVD
Autism	17483303	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Acute myeloid leukemia	19651601	CNVD
Sudden cardiac death	19188705	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:8 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:167821400-167829200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
2	chr6:167821600-167829400	Weak transcription	HUES6 Cell Line	embryonic stem cell
3	chr6:167822200-167829000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
4	chr6:167824400-167826200	Weak transcription	Gastric	stomach
5	chr6:167824400-167827000	Bivalent Enhancer	HepG2	liver
6	chr6:167824400-167829000	Weak transcription	H1 Cell Line	embryonic stem cell
7	chr6:167825200-167830200	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
8	chr6:167826200-167826400	Enhancers	Gastric	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links